{
      "ptx_code": "PTX070",
      "chem_name": "Rotenone",
      "casrn": "83-79-4",
      "dtxsid": "DTXSID6021248",
      "smiles": "[H][C@@]12COC3=C(C=C(OC)C(OC)=C3)[C@]1([H])C(=O)C1=CC=C3O[C@H](CC3=C1O2)C(C)=C",
      "inchikey": "JUVIOZPCNVVQFO-HBGVWJBISA-N",
      "label": "PTX070 | Rotenone",
      "pubchem_cid": "6758",
      "drugbank_id": "",
      "use_class": "Pesticide",
      "tox_class": "Neurotoxicity",
      "formula": "C23H22O6",
      "chem_name_user": "Rotenone",
      "mw_g_mol": "394.42",
      "solubility_h2o_mol_liter": "2.48e-05",
      "source_solubility_h2o": "COMPTOX",
      "henry_coefficient_atm_m3_mol": "1.81e-09",
      "source_henry": "COMPTOX",
      "log_kaw_kh_rt": "7.13",
      "source_kaw": "LSER eq 1",
      "pka_acid": "",
      "pka_base": "",
      "source_pka": "",
      "log_kow_liter_liter": "4.10",
      "source_kow": "Yalkowsky et al. Chemosphere 2002, 48, 487\u2013509",
      "log_dlipw_ph74_liter_liter": "4.22",
      "source_dlipw": "LSERD, eq. 1  (?mw=1)",
      "freely_dissolved_fraction": "0.12",
      "density_kg_liter": "1.29",
      "source_density": "COMPTOX",
      "boiling_point": "215.00",
      "source_boiling_point": "CompTox (Oxford University Chemical Safety Data (No longer updated)",
      "melting_point": "165.5; 176.0",
      "source_melting_point": "CompTox (Jean-Claude Bradley Open Melting Point Dataset; Jean-Claude Bradley Open Melting Point Dataset)",
      "vapor_pressure": "",
      "source_vapor_pressure": "",
      "baseline_drerio": "11.00",
      "baseline_dmagna": "11.90",
      "baseline_celegans": "26.38",
      "baseline_xlaevis": "20.50",
      "baseline_dmelanogaster": "100.44",
      "baseline_cells": "1.35e-05",
      "baseline_cells_generic_micromole_liter_free_ec10": "1.57e-06",
      "moa_drugbank": "",
      "protein_binding": "",
      "moa_t3db": "Rotenone works by interfering with the electron transport chain in mitochondria. Specifically, it inhibits the transfer of electrons from iron-sulfur centers in complex I to ubiquinone. This prevents NADH from being converted into usable cellular energy (ATP). ",
      "aop": [
            {
                  "AOP_id": 6,
                  "AOP_name": "Antagonist binding to PPAR\u03b1 leading to body-weight loss "
            },
            {
                  "AOP_id": 18,
                  "AOP_name": "PPAR\u03b1 activation in utero leading to impaired fertility in males "
            },
            {
                  "AOP_id": 34,
                  "AOP_name": "LXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 58,
                  "AOP_name": "NR1I3 (CAR) suppression leading to hepatic steatosis "
            },
            {
                  "AOP_id": 61,
                  "AOP_name": "NFE2L2/FXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 72,
                  "AOP_name": "Epigenetic modification of PPARG leading to adipogenesis "
            },
            {
                  "AOP_id": 123,
                  "AOP_name": "Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription "
            },
            {
                  "AOP_id": 318,
                  "AOP_name": "Glucocorticoid Receptor activation leading to hepatic steatosis "
            }
      ],
      "targets": [
            "25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",
            "5-hydroxytryptamine receptor 6",
            "ADP-ribosyl cyclase 1",
            "ATP-binding cassette sub-family G member 2",
            "Androgen receptor",
            "Bile salt export pump",
            "Bile salt sulfotransferase",
            "Bone morphogenetic protein receptor type-2",
            "C-C motif chemokine 2",
            "Cellular tumor antigen p53",
            "Cyclic AMP-responsive element-binding protein 3",
            "Cytochrome P450 19A1",
            "Cytochrome P450 1A1",
            "Cytochrome P450 2B6",
            "Cytochrome P450 2C19",
            "Cytochrome P450 2C9",
            "Cytochrome P450 3A4",
            "Cytochrome P450 3A5",
            "E-selectin",
            "Early activation antigen CD69",
            "Epidermal growth factor receptor",
            "Estrogen receptor alpha",
            "Glutathione S-transferase A2",
            "HLA class II histocompatibility antigen, DR alpha chain",
            "Interleukin-8",
            "Metal regulatory transcription factor 1",
            "Metal-response element-binding transcription factor 2",
            "Metalloproteinase inhibitor 1",
            "NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial",
            "NADH-ubiquinone oxidoreductase chain 1",
            "NADH-ubiquinone oxidoreductase chain 2",
            "NADH-ubiquinone oxidoreductase chain 3",
            "NADH-ubiquinone oxidoreductase chain 4",
            "Nuclear factor erythroid 2-related factor 2",
            "Nuclear receptor ROR-alpha",
            "Nuclear receptor subfamily 1 group I member 3",
            "POU domain, class 2, transcription factor 1",
            "Peroxisome proliferator-activated receptor alpha",
            "Prostaglandin E2 receptor EP2 subtype",
            "Retinoic acid receptor RXR-alpha",
            "Thyroid hormone receptor alpha",
            "Transient receptor potential cation channel subfamily A member 1",
            "Tumor necrosis factor",
            "Tumor necrosis factor receptor superfamily member 5",
            "Urokinase plasminogen activator surface receptor",
            "Urokinase-type plasminogen activator",
            "Vascular cell adhesion protein 1"
      ]
}